background
felin
leishmaniosi
caus
leishmania
infantum
consid
rare
diseas
endem
area
wherea
subclin
infect
common
immun
respons
play
key
role
drive
cours
l
infantum
infect
host
speci
howev
felin
cellmedi
immun
respons
l
infantum
infect
yet
investig
aim
studi
determin
cellmedi
immun
respons
specif
l
infantum
mean
interferon
ifn
releas
whole
blood
assay
cat
live
endem
area
sicili
catalonia
compar
antibodi
level
l
infantum
enzymelink
immunosorb
assay
elisa
immunofluoresc
antibodi
test
ifat
blood
parasit
load
retrovir
infect
result
cat
n
l
infantum
antibodi
neg
n
posit
test
cat
felin
immunodefic
viru
fiv
infect
felin
leukemia
viru
felv
infect
respect
thirtytwo
cat
produc
stimul
l
infantum
solubl
antigen
lsa
major
cat
produc
stimul
concanavalin
cona
six
cat
seroposit
three
elisa
five
ifat
polymeras
chain
reaction
pcr
neg
one
cat
antibodyand
pcrposit
signific
posit
correl
found
concentr
stimul
lsa
cona
serolog
pcr
test
associ
found
fiv
statu
lsa
product
combin
pcr
serolog
specif
concentr
result
found
cat
studi
expos
l
infantum
expect
cat
endem
area
produc
ex
vivo
blood
stimul
lsa
therefor
abl
activ
cellmedi
adapt
immun
respons
parasit
variabl
associ
antibodi
blood
pcr
posit
associ
assay
serolog
molecular
test
provid
better
estim
cat
exposur
l
infantum
leishmaniosi
vectorborn
diseas
human
anim
caus
europ
leishmania
infantum
transmit
femal
sand
fli
genu
phlebotomu
dog
consid
main
reservoir
l
infantum
clear
evid
wild
synanthrop
mammal
domest
cat
abl
infect
sand
fli
play
variabl
role
reservoir
system
accord
local
ecolog
peculiar
felin
leishmaniosi
fel
due
l
infantum
infect
describ
first
time
sergent
et
al
sinc
global
report
endem
area
subclin
felin
infect
common
area
canin
leishmaniosi
canl
endem
clinic
ill
due
fel
rare
clinic
diseas
frequent
associ
possibl
impair
immunocompet
case
retrovir
coinfect
immunosuppress
therapi
malign
neoplasia
immun
respons
play
crucial
role
control
leishmania
infect
albeit
differ
accord
host
speci
cell
modul
orient
cytokin
product
macrophag
reaction
parasit
antigen
process
cell
dendrit
cell
macrophag
present
l
infantum
antigen
cell
modul
type
immun
respons
helper
orient
immun
respons
associ
product
interferongamma
interleukin
il
tumor
necrosi
factor
alpha
stimul
phagocytosi
macrophag
product
nitric
oxid
reactiv
oxygen
intermedi
consequ
phagocytebas
parasit
intracellular
elimin
convers
dog
suscept
infect
diseas
progress
mediat
predominantli
nonprotect
helper
immun
respons
product
cytokin
transform
growth
factor
beta
associ
downregul
cellular
immun
respons
high
level
antibodi
l
infantum
dissemin
differ
felin
innat
adapt
immun
respons
might
account
observ
lower
preval
l
infantum
infect
well
clinic
leishmaniosi
cat
compar
dog
well
recogn
cat
appear
less
frequent
affect
arthropodborn
diseas
compar
dog
although
import
differ
known
canin
felin
immun
system
interestingli
best
knowledg
studi
far
evalu
l
infantumspecif
cellmedi
immun
cat
howev
detect
antigen
stimul
whole
blood
peripher
blood
mononuclear
cell
pbmc
use
cat
evalu
cellular
immun
respons
mechan
pathogen
eg
felin
coronaviru
toxoplasma
gondii
main
aim
studi
determin
l
infantumspecif
cellular
immun
respons
cat
mean
evalu
product
stimul
blood
cat
live
endem
area
canl
catalonia
sicili
correl
l
infantum
antibodi
level
blood
parasitemia
retrovir
statu
ambulatorio
veterinario
santa
lucia
lipari
messina
inclus
criteria
enrol
includ
exposur
least
one
sandfli
season
treatment
repel
ectoparasiticid
ie
pyrethroid
product
sex
age
class
breed
clinic
statu
lifestyl
pet
cat
indoor
outdoor
number
stray
cat
sampl
site
summar
tabl
age
classifi
follow
young
month
adult
month
old
month
clinic
statu
cat
defin
sick
appar
healthi
base
data
avail
histori
physic
examin
sick
cat
consid
clinic
sign
compat
fel
ie
lymph
node
enlarg
skin
mucos
eye
lesion
stomat
weight
loss
chronic
kidney
diseas
anaemia
found
previous
describ
appar
healthi
cat
consid
clinic
sign
present
except
four
cat
admit
trauma
also
includ
group
one
millilit
blood
asept
put
heparin
tube
use
whole
blood
assay
within
h
blood
sampl
edta
blood
blood
serum
also
obtain
immedi
aliquot
store
process
dna
extract
serolog
investig
respect
whole
blood
assay
perform
previous
describ
dog
minor
modif
adapt
techniqu
smaller
volum
blood
avail
heparin
blood
dilut
ratio
medium
five
day
supernat
collect
unstimul
cultur
cell
two
aliquot
dilut
blood
respect
cultur
concanavalina
cona
l
infantum
solubl
antigen
lsa
subsequ
recov
supernat
stimul
blood
cell
felin
concentr
determin
use
specif
duoset
elisa
develop
sistem
r
abingdon
uk
accord
manufactur
instruct
modif
standard
curv
start
pgml
serial
dilut
made
concentr
pgml
reach
duplic
supernat
obtain
whole
blood
cultur
test
elisa
plate
optic
densiti
measur
elisa
reader
antho
cambridg
uk
wavelength
nm
tabl
age
class
sex
breed
lifestyl
clinic
statu
cat
studi
accord
geograph
distribut
indoor
outdoor
column
concern
lifestyl
pet
cat
cat
n
standard
curv
calcul
use
comput
gener
four
paramet
logist
curvefit
program
myassay
http
wwwmyass
ayscom
cat
classifi
produc
l
infantumspecif
concentr
subtract
valu
obtain
supernat
unstimul
cell
cultur
higher
last
detect
dilut
standard
curv
pgml
similarli
cat
classifi
nonproduc
l
infantumspecif
concentr
subtract
valu
obtain
supernat
unstimul
cell
cultur
less
pgml
undetect
level
cat
classif
made
product
obtain
cona
stimul
whole
blood
cultur
antil
infantum
igg
antibodi
detect
use
l
infantum
strain
antigen
produc
crenal
centro
di
referenza
nazional
per
la
leishmaniosi
palermo
itali
fluorescein
anticat
immunoglobulin
g
igg
antibodi
work
antifelin
igg
hl
fitc
fuller
laboratori
fullerton
ca
usa
use
manufactur
protocol
follow
end
point
titer
posit
sampl
determin
prepar
serial
dilut
serum
start
cutoff
valu
posit
set
fluoresc
microscop
read
made
uniqu
oper
mm
elisa
perform
previous
describ
plate
includ
serum
sick
cat
cypru
confirm
infect
l
infantum
posit
control
serum
cat
area
leishmaniosi
endem
neg
control
sampl
run
duplic
cutoff
establish
elisa
unit
eu
mean
standard
deviat
sera
cat
uk
nonendem
area
total
dna
extract
edta
blood
use
dna
gene
extract
kit
sigma
aldrich
saint
loui
mo
usa
follow
manufactur
instruct
modif
forti
microlit
proteinas
k
solut
ad
sampl
four
hundr
microlit
whole
blood
use
sampl
blood
clinic
healthi
noninfect
cat
use
control
dna
contamin
everi
dna
extract
perform
realtim
polymeras
chain
reaction
rtpcr
carri
realtim
system
biorad
laboratori
srl
hercul
ca
usa
use
taqman
master
mix
appli
biosystem
thermofish
waltham
usa
perform
previous
describ
minimum
sampl
size
cat
calcul
cat
enrol
base
preval
felin
l
infantum
infect
area
studi
catalonia
sicili
assumpt
confid
level
precis
fisher
exact
test
use
compar
group
defin
categor
variabl
result
test
l
infantum
exposur
cat
pass
agostinopearson
normal
test
accordingli
mannwhitney
utest
use
compar
unmatch
continu
data
wilcoxon
signedrank
test
compar
pair
continu
variabl
spearman
correl
coeffici
calcul
evalu
relationship
elisa
ifat
pcr
result
level
antileishmania
antibodi
l
infantum
dna
blood
cat
studi
pvalu
consid
signific
agostinopearson
normal
test
fisher
exact
test
perform
use
prism
mac
io
test
perform
use
spss
softwar
window
final
cohen
kappa
coeffici
measur
analyz
result
elisa
ifat
blood
pcr
http
idost
atist
icscomcohen
kappa
freecalcu
lator
sex
breed
age
class
lifestyl
origin
region
municip
clinic
statu
cat
includ
studi
summar
tabl
median
age
cat
month
percentil
month
interquartil
rang
iqr
month
differ
two
region
relat
variabl
sex
breed
age
class
lifestyl
cat
convers
cat
sicili
frequent
found
sick
compar
catalan
cat
fisher
exact
test
p
result
serolog
test
shown
tabl
fig
slight
posit
correl
spearman
correl
coeffici
r
p
found
elisa
ifat
howev
cat
posit
ifat
andor
elisa
posit
test
agreement
found
test
compar
cohen
kappa
coeffici
ie
slight
agreement
beyond
chanc
differ
found
regard
seroposit
variabl
studi
ifat
result
base
cat
proveni
clinic
statu
summar
pcr
result
base
cat
proveni
clinic
statu
summar
tabl
cat
leishmaniapcr
posit
fig
median
parasit
load
l
infantum
amastigotesml
leishmaniapcr
posit
cat
frequent
posit
serolog
ifat
elisa
leishmaniapcr
neg
cat
ifat
elisa
fisher
exact
test
p
addit
antibodi
level
measur
ifat
mannwhitney
utest
z
p
elisa
mannwhitneyu
test
z
p
leishmaniapcr
posit
cat
significantli
higher
compar
leishmaniapcr
neg
cat
moreov
posit
correl
found
pcr
elisa
spearman
correl
coeffici
r
p
agreement
cohen
kappa
coeffici
ie
fair
agreement
well
posit
correl
pcr
ifat
spearman
correl
coeffici
r
p
agreement
cohen
kappa
coeffici
ie
slight
agreement
differ
found
posit
pcr
preval
accord
variabl
studi
thirteen
cat
antibodyposit
fiv
antigenposit
felv
tabl
fiv
felv
coinfect
never
detect
felvposit
cat
catalonia
differ
fiv
preval
cat
enrol
sicili
catalonia
tabl
moreov
statist
differ
preval
antil
infantum
antibodi
leishmania
dna
posit
cat
posit
fiv
felv
compar
neg
similarli
statist
differ
found
level
antil
infantum
antibodi
l
infantum
parasit
load
fivor
felvposit
cat
neg
one
interestingli
four
fivand
two
felvposit
cat
also
posit
one
l
infantum
diagnost
test
one
felvand
two
fivposit
cat
produc
lsa
stimul
moreov
two
posit
serolog
test
blood
pcr
convers
cat
l
infantum
retroviru
neg
produc
lsa
stimul
statist
differ
product
lsa
cona
stimul
fivor
felvposit
neg
cat
frequenc
cat
produc
stimul
lsa
cona
summar
tabl
accord
proveni
clinic
statu
higher
number
cat
produc
stimul
cona
lsa
fisher
exact
test
p
tabl
level
accord
serolog
pcr
result
clinic
statu
summar
tabl
median
concentr
produc
cat
significantli
lower
concentr
obtain
cona
stimul
pgml
pg
ml
wilcoxon
signedrank
test
z
p
uniqu
cat
posit
leishmaniapcr
l
infantum
amastigotesml
test
high
posit
ifat
titer
elisa
eu
cat
adult
felvposit
suffer
squamou
cell
carcinoma
leishmania
amastigot
detect
cytolog
evalu
neoplast
cutan
lesion
sick
appar
healthi
cat
preval
individu
tabl
howev
sick
cat
significantli
higher
level
lsa
mannwhitney
utest
z
p
tabl
preval
cat
produc
stimul
cona
group
tabl
howev
among
cat
expos
l
infantum
ie
posit
least
one
specif
test
sick
individu
n
significantli
higher
median
concentr
pgml
pgml
appar
healthi
cat
n
pgml
pgml
mannwhitney
utest
z
p
concentr
produc
stimul
cona
significantli
higher
group
mannwhitney
utest
z
p
tabl
concentr
cona
lsa
stimul
posit
correl
spearman
correl
coeffici
r
p
addit
elisa
antibodi
level
posit
correl
overal
l
infantum
preval
calcul
pcr
serolog
lsa
assay
obtain
popul
studi
fig
differ
found
catalonia
sicili
site
region
studi
appar
healthi
sick
cat
knowledg
studi
demonstr
first
time
cat
natur
expos
l
infantum
infect
produc
ex
vivo
whole
blood
stimul
l
infantum
antigen
occur
dog
human
laboratori
anim
parasitespecif
product
found
enrol
cat
associ
antibodi
product
seven
cat
studi
type
adapt
immun
respons
therefor
variabl
combin
singl
cat
wide
immunolog
spectrum
may
exist
also
cat
alreadi
report
dog
human
present
studi
aim
evalu
parasit
cell
mediat
immun
clinic
case
fel
base
data
avail
physic
examin
frequenc
individu
differ
appar
healthi
sick
cat
similarli
differ
preval
sick
cat
cat
posit
serolog
blood
pcr
test
howev
sick
cat
produc
significantli
higher
level
moreov
uniqu
cat
clinic
fel
confirm
cytolog
despit
possibl
immunosuppress
due
felv
infect
neoplasia
cat
reach
level
around
median
valu
present
studi
retrovir
infect
per
se
affect
adapt
immun
respons
cat
l
infantum
limit
low
number
fiv
n
felv
n
infect
enrol
cat
dog
mild
moder
canl
produc
lack
product
restrict
sever
diseas
prospect
clinic
studi
cat
confirm
clinic
leishmaniosi
need
evalu
possibl
marker
stage
sever
diseas
evalu
efficaci
therapi
document
dog
product
stimul
cona
obtain
almost
cat
associ
variabl
includ
clinic
statu
retrovir
infect
exposur
l
infantum
find
similar
data
studi
canl
expect
concentr
significantli
higher
posit
correl
product
suggest
nonspecif
cell
activ
surprisingli
consid
cat
expos
l
infantum
ie
posit
least
one
specif
test
perform
sick
individu
produc
significantli
higher
level
cona
compar
appar
healthi
individu
find
unusu
difficult
significantli
lower
concentr
observ
preval
antil
infantum
antibodi
obtain
studi
combin
ifat
elisa
result
similar
two
region
approxim
valu
easi
therefor
explain
higher
frequenc
level
posit
elisa
sicilian
cat
cat
frequent
found
sick
compar
catalan
cat
tabl
previou
studi
conduct
sicili
base
ifat
cutoff
use
antil
infantum
antibodi
preval
rang
convers
two
studi
evalu
antil
infantum
antibodi
preval
catalonia
use
elisa
antibodi
preval
respect
howev
alreadi
report
found
posit
correl
elisa
ifat
parasit
load
cat
measur
blood
pcr
thu
posit
cat
possibl
miss
blood
sensit
tissu
detect
l
infantum
dna
dog
likewis
cat
howev
pcrposit
cat
also
antibodyposit
level
l
infantum
dna
blood
posit
correl
antibodi
level
cat
common
find
cat
l
infantum
endem
area
compar
studi
use
two
serolog
techniqu
therefor
sensit
serolog
increas
studi
cat
neg
l
infantum
antibodi
dna
detect
blood
find
mean
combin
serolog
molecular
test
l
infantumspecif
evalu
offer
accur
overal
estim
exposur
l
infantum
cat
studi
fact
preval
l
infantum
blood
pcr
antibodi
detect
combin
result
obtain
serolog
molecular
test
increas
percentag
posit
pcr
posit
cat
also
posit
l
infantum
antibodi
fig
howev
also
consid
posit
l
infantumspecif
product
overal
l
infantum
preval
rais
data
confirm
consider
percentag
studi
cat
contact
l
infantum
detect
cellmedi
immun
respons
measur
specif
product
provid
better
estim
exposur
cat
l
infantum
endem
area
seen
dog
differ
techniqu
expect
cat
endem
area
produc
ex
vivo
blood
stimul
lsa
therefor
abl
activ
cellmedi
adapt
immun
respons
parasit
variabl
associ
antibodi
blood
pcr
posit
associ
assay
serolog
molecular
test
provid
better
estim
cat
exposur
l
infantum
canl
canin
leishmaniosi
cona
concanavalin
produc
whole
blood
assay
stimul
cona
dth
delay
type
hypersensit
reaction
elisa
enzymelink
immunosorb
assay
fel
felin
leishmaniosi
felv
felin
leukemia
viru
fiv
felin
immunodefici
viru
ifat
indirect
fluoresc
antibodi
test
cat
nonproduc
whole
blood
assay
stimul
lsa
cat
produc
whole
blood
assay
stimul
lsa
igg
immunoglobulin
g
lpa
lymphocyt
prolifer
assay
lsa
leishmania
solubl
antigen
pbmc
peripher
blood
mononuclear
cell
rtpcr
realtim
polymeras
chain
reaction
